2017-2018 Expansion StageFormed the core competitiveness in the field of oncological and innovative drug R&D with several NDAs passing the CFDI inspections.Providing clinical pharmacology service: Beijing Lingchu Medical Technology Co., Ltd.Founded R&G US Inc. to provide simultaneous submission services in China and US, stepping forward to a higher level of internationalization.
2015-2016 Stable StagePursued excellence and expanded innovative drug clinical trial CRO business with focus on the development of cancer project. The number of clinical services for innovative drugs is far ahead.Acquired the central laboratory, HQ Bioscience Co., Ltd.Established Aikeman Information Technology Co., Ltd to provide global data system service and prepare for international business.
2013-2014 Development StagePrepared for global data system.Won the title of "CRO Company with the Most Investment Value".
2009-2012 Entrepreneurial StageEstablished ties with national and international customers in CRO business. Established the wholly-owned subsidiary, SMS Clinical Study Co., Ltd.
2008Founded R&G PharmaStudies Co., Ltd.
